EKSO: Ekso Bionics Holdings, Inc. - Summary | Jitta

Ekso Bionics Holdings, Inc.

NASDAQ:EKSO

Notice
Stock's price has been unchanged for more than a week.
Price
$11.80
Loss Chance
57.9%
1.59JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (34)
Recent Business Performance (11)
Financial Strength (27)
Return to Shareholders (3)
Competitive Advantage (23)
Jitta Signs
SG&A to SalesDecreasing
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 40.62% in the last quarter (yoy)
CapExVery High
Key Stats
Jitta Score
Jitta Line
1.59
100.00%
2.43
408.28%
2.43
408.28%
4.41
53.66%
3.32
38.04%
2.67
16.43%
COMPANY DESCRIPTION
As of May 5, 2026, Ekso Bionics Holdings, Inc. was acquired by Applied Digital Cloud Corporation, in a reverse merger transaction. Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton. It also develops Ekso Nomad, a power Knee Ankle Foot Orthosis or KAFO; and MediTouch BalanceTutor rehabilitation system, a multidirectional perturbation treadmill outfitted. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.